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TRF1 is a critical regulator of telomere length. As
such, TRF1 levels are regulated by ubiquitin-depen-
dent proteolysis via an SCF E3 ligase where Fbx4
contributes to substrate specification. Here, we
report the crystal structure of theFbx4-TRF1complex
at 2.4 A˚ resolution. Fbx4 contains an unusual sub-
strate-binding domain that adopts a small GTPase
fold. Strikingly, this atypical GTPase domain of Fbx4
binds to a globular domain of TRF1 through an inter-
molecular b sheet, instead of recognizing short
peptides/degrons as often seen in other F-box pro-
tein-substrate complexes. Importantly, mutations
in this interface abrogate Fbx4-dependent TRF1
binding and ubiquitination. Furthermore, the data
demonstrate that recognition of TRF1 by SCFFbx4 is
regulated by another telomere protein, TIN2. Our
results reveal an atypical small GTPase domainwithin
Fbx4 as a substrate-binding motif for SCFFbx4 and
uncover a mechanism for selective ubiquitination
and degradation of TRF1 in telomere homeostasis
control.
INTRODUCTION
Telomeres cap the ends of chromosomes and are essential for
genome integrity in all eukaryotes (Blackburn, 2001). Telomeres
consist of tandem repeat sequences that are synthesized by
a special reverse transcriptase called telomerase (Cech, 2004).
Telomerase activity is suppressed in somatic cells, where telo-
mere tract shortening is associated with cellular senescence
and acts as a molecular clock that regulates cellular and organ-
ismal life span (Wright and Shay, 1992). In contrast, telomerase
activity is constantly maintained in stem cells and most tumor
cells (Kim et al., 1994). Telomere length in these telomerase-con-
taining cells does not increase without control, but instead it is214 Developmental Cell 18, 214–225, February 16, 2010 ª2010 Elsevtightly regulated within a narrow range of size distribution
(Counter et al., 1992). A key regulator of human telomere length
is the telomere repeat binding protein TRF1, which negatively
regulates telomere elongation by telomerase (van Steensel and
de Lange, 1997). Binding along the duplex region of telomeres,
TRF1 functions as a measuring device to monitor telomere
length and acts in cis to regulate access of telomerase to chro-
mosome termini (van Steensel and de Lange, 1997). The amount
of TRF1 that is bound to telomeres directly correlates with telo-
mere length; overexpression of TRF1 results in gradual telomere
shortening, whereas inhibition of TRF1 binding to telomeres
induces a progressive increase in telomere length (van Steensel
and de Lange, 1997).
Recent genetic and molecular studies have revealed that
telomere-TRF1 association is tightly regulated by a series of
sequential posttranslational modification events. TRF1 is initially
poly-(ADP-ribosyl)ated by tankyrase 1, a multifunctional poly
(ADP-ribose) polymerase (Cook et al., 2002; Smith and de
Lange, 2000; Smith et al., 1998). ADP-ribosylation of TRF1 by
tankyrase 1 releases TRF1 from telomeres (Chang et al., 2003).
TRF1 is then polyubiquitinated and degraded through the pro-
teasome pathway (Chang et al., 2003; Lee et al., 2006). Although
poly-(ADP-ribosyl)ation is not required for TRF1 ubiquitination
in vitro, the catalytic activity of tankyrase 1 is essential for
TRF1 degradation in vivo; that is, TRF1 is ubiquitinated only
upon release from telomeres (Chang et al., 2003).
Ubiquitination of TRF1 is mediated by the F-box protein Fbx4
(Lee et al., 2006). F-box proteins typically function as substrate-
specific adaptor subunits of the SCF (Skp1-Cul1/Rbx1-F-box
protein) ubiquitin E3 ligases, which regulate a broad range of
cellular processes in eukaryotes (Petroski and Deshaies, 2005).
Besides an F-box domain that binds to Skp1, the F-box proteins
contain various substrate interaction domains, based on which,
F-box proteins fell into three major classes (Jin et al., 2004). The
two largest classes, named Fbw and Fbl, contain WD-40 repeat
and leucine-rich repeat domains, respectively (Jin et al., 2004).
Fbx4 belongs to the third class, Fbx, and lacks previously
identified protein interaction domains outside of the F box
(Figure 1A). Therefore, the molecular basis of how Fbx4 recog-
nizes TRF1 and mediates its degradation remains unknown.ier Inc.
Figure 1. Overview of the Fbx4G-TRF1TRFH Complex Structure
(A) Domain organization of the Fbx4 and TRF1 polypeptide chains. In Fbx4, the
F box is colored in green and the C-terminal Fbx4G domain in cyan. In TRF1,
the N-terminal acidic region is in red, the C-terminal Myb domain in slate,
and the TRFH domain in yellow. The shaded area between Fbx4 and TRF1
indicates that the Fbx4-TRF1 interaction is mediated by Fbx4G and TRF1TRFH.
(B) Ribbon diagram of the dimeric Fbx4G-TRF1TRFH complex. Fbx4G and
TRF1TRFH are colored in cyan and yellow, respectively, in one complex, and
blue and orange in the other. The secondary structure elements are labeled.
(C) Surface representation indicates that the dimeric Fbx4G-TRF1TRFH
complex adopts a saddle-shaped conformation. The orientation of complex
is rotated by 90 about a horizontal axis relative to the complex in (B).
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Selective Ubiquitination of TRF1 by SCFFbx4Here, we report the 2.4 A˚ resolution crystal structure of the
Fbx4-TRF1 complex, which unexpectedly reveals that Fbx4
contains a small GTPase fold. This substrate-binding domain
recognizes a globular domain of TRF1 instead of short degron
peptides seen in all other available F-box protein-substrateDevelopmcomplex structures (Petroski and Deshaies, 2005; Ravid and
Hochstrasser, 2008). We show that the telomere-bound TRF1
is protected from SCFFbx4-mediated ubiquitination by another
telomere protein, TIN2 (Chen et al., 2008; Kim et al., 1999).
Combining structural, mutational, and biochemical analyses,
we propose a coherent model for TRF1 regulation by SCFFbx4.RESULTS
Overview of the Fbx4-TRF1 Complex
A previous study reported that a fragment of Fbx4 (residues 171–
308) C-terminal to the F-box motif interacts with the TRFH
domain of TRF1 (TRF1TRFH) (Lee et al., 2006). However, attempts
to express and purify Fbx4171–308 yielded insoluble proteins (data
not shown). Examination of the primary sequence and predicted
secondary structure of Fbx4 identified a putative globular
domain (residues 162–387). Indeed, recombinant Fbx4162–387
formed a stable complex with TRF1TRFH (see Figures S1A and
S1B available online).
To gain insights into the molecular basis of TRF1 recognition by
Fbx4, we obtained crystals of the Fbx4162–387-TRF1TRFH complex
and determined its structure by multiple-wavelength anomalous
dispersion (MAD) at a resolution of 2.4 A˚ (Figure 1B). The calcu-
lated electron density map allowed unambiguous tracing of
most of the complex except a 38-residue disordered loop in
Fbx4 (residues 240–277) (Figure S1C). The complex structure
has been refined to an R value of 23.7% (Rfree = 26.3%) with
good geometry (Table 1).
The Fbx4162–387-TRF1TRFH complex structure reveals a 2:2
stoichiometry between Fbx4162–387 and TRF1TRFH, consistent
with the observed molecular weight of the complex (97 kDa)
by gel filtration chromatographic analysis (Figure S1A). The
complex has a saddle-shaped structure measuring linear dimen-
sions of approximately 100 A˚3 85 A˚3 75 A˚ (Figures 1B and 1C).
Fbx4162–387 and TRF1TRFH interact through complementary
hydrophobic surfaces (Figure S1D). Each Fbx4162–387 molecule
contacts only one subunit of TRF1TRFH that does not overlap
the TRF1TRFH dimeric interface (Figure 1B). The formation of
the binary complex causes the burial of 1,300 A˚ of surface
area at the interface. The homodimeric TRF1TRFH forms the
‘‘pommel’’ and ‘‘cantle’’ of the ‘‘saddle,’’ with each TRF1TRFH
comprising ten a helices (Figures 1B and 1C). Superposition
analysis shows that the structure of TRF1TRFH remains largely
unchanged with or without Fbx4162–387 bound except for loop
L34 (Figure S1E). L34 is highly flexible and partially disordered in
the unliganded TRF1TRFH (Fairall et al., 2001).
The structure of Fbx4162–387 adopts a compact, globular fold
featuring a highly curved seven-stranded b sheet surrounded
by five a helices (Figures 1B and 2B; Figure S2). Strikingly,
although primary sequence analysis failed to identify any known
protein motif in Fbx4162–387, an unbiased search of the database
using Dali (Holm and Sander, 1991) revealed unequivocal struc-
tural resemblance of Fbx4162–387 with more than 400 Ras super-
family small GTPases (Colicelli, 2004; Wennerberg et al., 2005).
Each of these GTPases can be superimposed onto Fbx4162–387
with a root-mean-square deviation (rmsd) of3 A˚ in the positions
of over 135 Ca atoms of equivalent residues. Thus, this analysis
identified Fbx4162–387 as a domain belonging to the Rasental Cell 18, 214–225, February 16, 2010 ª2010 Elsevier Inc. 215
Table 1. Data Collection, Phasing, and Refinement Statistics
Se-Met
Data Collection
Data Set Peak Inflection
Space group P43212 P43212
Cell dimensions
—a, b, c (A˚) 68.097, 68.097,
234.421
68.197, 68.197,
234.562
—a, b, g () 90, 90, 90 90, 90, 90
Wavelength (A˚) 0.9792 0.9794
Resolution (A˚)
(high-resolution shell)
50-2.4 (2.49-2.4) 50-2.5 (2.59-2.5)
Rmerge (%)
(high-resolution shell)
0.081 (0.279) 0.082 (0.502)
I/s (high-resolution cell) 54.3 (4.4) 35.1 (2.5)
Completeness (%)
(high-resolution shell)
96.2 (76.5) 92.3 (41.8)
Redundancy
(high-resolution shell)
11.4 (5.1) 12.3 (6.2)
Phasing
Acentric Phasing
Power
Centric Phasing
Power
Se peak anomalous 1.782
Se inflection isomorphous 0.253 0.237
Se inflection anomalous 0.539
FOM
Acentric reflections 0.387
Centric reflections 0.110
Refinement
Resolution (A˚) 50-2.4
Number of reflections 38,593
Rwork/Rfree (%) 23.74/26.34
No. atoms
—Protein 3077
—Water 60
B factors
—Protein 56.9
—Water 45.8
Rms deviations
—Bond lengths (A˚) 0.008023
—Bond angles () 1.28514
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Selective Ubiquitination of TRF1 by SCFFbx4superfamily of small GTPases. Hereafter, we will refer to
Fbx4162–387 as Fbx4G (Fbx4 GTPase domain) (Figure 1A).
Fbx4G Contains an Atypical Small GTPase Domain
The GTP hydrolyzing activity of classical Ras superfamily
GTPases relies on five highly conserved loop regions: the P
loop is responsible for binding of the a- and b-phosphate groups;
Switch I and Switch II provide residues for Mg2+ and g-phos-
phate binding; and the G4 and G5 loops recognize the guanine
base (Figure 2A) (Paduch et al., 2001). Despite the high degree
of overall structural similarity, the loop regions of Fbx4G, relative
to classical small GTPases, are markedly divergent. First, Fbx4G
lacks most of the conserved residues that are important for GTP216 Developmental Cell 18, 214–225, February 16, 2010 ª2010 Elsevbinding (Figure 2A). Second, the P- and G4 loops adopt different
conformations than those observed in classical small GTPase
proteins and preclude Fbx4G from binding of GTP (Figure 2B).
Third, Fbx4G has a very long Switch II loop (40 residues as
compared to 8 residues in classical GTPases), which is disor-
dered in the Fbx4G-TRF1TRFH complex structure (Figure 2B).
Thus, these sequence and structure analyses suggested
that Fbx4G would not bind GTP. Through use of a fluorescent
polarization assay, we found that neither Fbx4G nor the Fbx4G-
TRF1TRFH complex detectably bound to GTPgS, whereas
RhoA, a well-characterized small GTPase, associated with the
nucleotide (Figure 2C). Furthermore, we have also tested several
other nucleotides, including ATP, ADP, and TTP, and found out
none of these nucleotides could associate with Fbx4 (data not
shown). Taken together, we conclude that while Fbx4G contains
an atypical small GTPase domain, it lacks any detectable poten-
tial to effectively bind or coordinate GTP.
TRF1 Recognition by Fbx4
The structure of the Fbx4G-TRF1TRFH complex reveals the
molecular basis by which Fbx4 recognizes TRF1 (Figure 3).
The primary feature of the Fbx4G-TRF1TRFH interaction is an
antiparallel intermolecular b sheet interaction involving b6 of
Fbx4G and an induced b strand bA between helices a2 and a3
of TRF1TRFH, resulting in an eight-strand b sheet extending
over both molecules (Figure 3A). bA corresponds to loop L23 in
the unliganded TRF1TRFH structure (Fairall et al., 2001). There
are three backbone hydrogen-bonding interactions between
Fbx4G b6 and TRF1TRFH bA (Figure 3B). It is a common theme
that small GTPase proteins interact with their effectors by form-
ing an intermolecular b sheet (Herrmann, 2003). However, Fbx4G
uses b6 to bind to TRF1TRFH, whereas most GTPases employ
their b2 on the GTP-binding edge of the b sheet to contact their
effectors (Figure S3) (Herrmann, 2003).
In addition to the intermolecular b sheet, the formation of the
Fbx4G-TRF1TRFH complex is reinforced by the aD helix of
Fbx4G, which contacts TRF1 through extensive van der Waals
interactions. This short helix packs against a concave-shaped
hydrophobic surface that spans both molecules with aC, b4,
b5, and b6 of Fbx4G on one side and a2, a3, and bA of TRF1TRFH
on the other (Figures 3A–3C). Particularly, located at the center of
the aD helix is Phe342, whose side chain sits snugly on a comple-
mentary surface formed by a cluster of hydrophobic residues of
TRF1TRFH (Figures 3B and 3C). These van der Waals contacts are
further buttressed by two electrostatic interactions. The side
chain amino group of Fbx4 Asn351 forms a hydrogen bond
with the carboxyl group of TRF1 Glu162, while the imidazole
ring of Fbx4 His346 donates another one to the phenol ring of
TRF1 Tyr124 (Figure 3B).
To corroborate our structural analysis, we examined whether
mutations of the interface residues of TRF1TRFH or Fbx4G could
weaken or disrupt the Fbx4-TRF1 interaction. In support of the
crystal structure, substitution of the conserved leucine residues
of TRF1TRFH (Leu115 or Leu120) on the interface with a positively
charged and bulkier arginine residue was sufficient to abolish
the interaction with Fbx4G in both yeast two-hybrid and in vitro
GST-pull-down assays (Figures 3B, 3C, 3E, and 3F). Similarly,
Fbx4G mutations C341W and A345R on the other side of the in-
terface also impaired the interaction (Figures 3B, 3C, 3E, and 3F).ier Inc.
Figure 2. Fbx4G Is an Atypical Small GTPase
Domain without GTP Binding Activity
(A) Sequence alignment in the loop regions of
Fbx4G and a group of small GTPases. The
conserved residues important for nucleotide
binding are highlighted in different colors; the P
loop is in green, Switch I in yellow, Switch II in
cyan, G4 in orange, and G5 in magenta.
(B) The conformation of Fbx4G observed in the
crystal structure is incompatible with GTP binding.
Left: ribbon representation of Fbx4G with modeled
GTP and Mg2+. The P loop, Switch II, and the G4
loop of Fbx4G block the binding of GTP. Right:
ribbon representation of the Arf1A-GTP complex
(PDB: 2J59). The coloring scheme of the loop
regions is the same as in (A). GTP is shown as
a stick model and Mg2+ as a black ball.
(C) Time courses of GTP binding for Fbx4G and the
Fbx4G-TRF1TRFH complex. GTP binding was
monitored by the increase in fluorescence millipo-
larization (mP) of a fluorescent GTP analog as it
was bound. In this experiment, neither Fbx4G nor
the Fbx4G-TRF1TRFH complex bound to GTP.
RhoA (a small GTPase) and p63RhoGEF (a non-
GTPase protein) were used as positive and
negative controls, respectively.
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Selective Ubiquitination of TRF1 by SCFFbx4By contrast, four control mutations of Fbx4 or TRF1, designed to
eliminate the crystal packing contacts between Fbx4G and
TRF1TRFH, had no detectable effect on complex formation
(Figure 3E). Therefore, we conclude that the hydrophobic inter-
face between Fbx4 and TRF1 is necessary for the binding of
Fbx4 to TRF1.
Fbx4 Does Not Bind to TRF2
TRF1 and TRF2 are two closely related paralogous proteins
(Broccoli et al., 1997). Despite the structural similarities of the
TRFH domains of TRF1 and TRF2, there are some sequence
variations in the TRFH domains between these two paralogs
(Chen et al., 2008; Fairall et al., 2001). We asked whether Fbx4
also binds TRF2. However, we failed to detect Fbx4-TRF2
binding using both yeast two-hybrid and GST pull-down assays
(Figures 3E and 3F). Comparison of the TRFH domains of TRF1
and TRF2 revealed that structural differences in loop L23 are
likely responsible for the ability of Fbx4 to distinguish between
these two paralogous proteins. In TRF1, a glycine residue
(Gly111) is at the beginning of loop L23 (strand bA in the
Fbx4G-TRF1TRFH complex) (Figure 3D). Its unusual dihedralDevelopmental Cell 18, 214–225,angles allow L23 to adopt a distinct
conformation that lines up the backbone
of L23 for the optimal intermolecular
b sheet interaction with b6 of Fbx4G
(Figure 3D). In addition, the side chains
of Leu112 and Leu115 of TRF1 rotate
away from strand b6 of Fbx4 and form
part of the hydrophobic surface that
contacts helix aD of Fbx4G (Figure 3D).
In contrast, the overall geometry of
TRF2 loop L23 prevents the formation of
the intermolecular b sheet with Fbx4G
(Figure 3D). Most notably, the side chain of TRF2, Leu93, rotates
almost 180 relative to the position of Leu115 in TRF1, resulting
in a clash with b6 of Fbx4G (Figure 3D). This structural analysis
provides the rationale for the binding specificity of Fbx4 for
TRF1. Consistent with this notion, substituting the correspond-
ing residues from TRF2 for TRF1 abrogates TRF1 ubiquitination
(data not shown).
SCFFbx4 Is an E3 Ubiquitin Ligase for TRF1
To examine the functional significance of the Fbx4-TRF1 interac-
tion, we reconstituted Fbx4-dependent TRF1 ubiquitination
in vitro using highly purified recombinant protein components.
We initially incubated wild-type (WT) TRF1 with recombinant
ubiquitin, E1, UbcH5a (E2), and the SCFFbx4 complex (E3) to-
gether with adenosine triphosphate (ATP). Polyubiquitination of
WT TRF1 was readily detected in an F-box- and ubiquitin-depen-
dent manner (Figure 4A, compare lanes 2 and 8 with 10). Omis-
sion of any component required in the ubiquitin transfer reaction
abrogated polyubiquitination of TRF1 (Figure 4A, compare lanes
3, 4, 5, 6, and 7 with 10). In addition, when Fbx4 was replaced
with another F-box protein, Skp2, polyubiquitination of TRF1February 16, 2010 ª2010 Elsevier Inc. 217
Figure 3. Recognition of TRF1 by Fbx4
(A) An overall view of the Fbx4G-TRF1TRFH interac-
tion. The interacting structural elements of Fbx4G
(b6 and aD) and TRF1TRFH (bA, a2, and a3) are
colored in cyan and orange, respectively, and the
rest of Fbx4G and TRF1TRFH in blue and yellow.
(B) Stereo view of the Fbx4G-TRF1TRFH interface.
Fbx4G and TRF1TRFH interacting residues are pre-
sented as stick models. The Fbx4G-TRF1TRFH
intermolecular hydrogen bonds are shown as
dashed magenta lines.
(C) The aD helix of Fbx4G sits on a hydrophobic
surface formed by bA and helices a2 and a3 of
TRF1TRFH.
(D) Fbx4G binding is TRF1TRFH specific. Loop L23
of TRF2TRFH (green) adopts a different conforma-
tion from that of TRF1TRFH (yellow) so that it cannot
form an intermolecular b sheet interaction with
Fbx4G. The surface representation shows that
the side chain of TRF2 Leu93 collides with b6 of
Fbx4G.
(E) Effects of the Fbx4 and TRF1 mutations on the
Fbx4-TRF1 interaction in a yeast two-hybrid
assay. Interaction of LexA-TRF1 with GAD-Fbx4
was measured as b-galactosidase activity. Data
are average of three independent b-galactosidase
measurements normalized to the wild-type Fbx4-
TRF1 interaction, arbitrarily set to 100. Error bars
in the graph represent standard deviation.
(F) GST pull-down assay of the wild-type and
mutant Fbx4G-TRF1TRFH interactions.
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Selective Ubiquitination of TRF1 by SCFFbx4was drastically reduced, confirming the substrate specificity of
Fbx4 (Figure 4A, compare lanes 9 with 10). Consistent with the
yeast two-hybrid and in vitro binding data (Figures 3E and 3F),
the ubiquitination of a TRF1 mutant (TRF1L115R/L120R) was greatly
reduced compared with that of WT TRF1 (Figure 4B, compare
lanes 2 with 6). Similarly, addition of a mutant SCFFbx4 complex
(SCFFbx4C341W/A345R) instead of the WT complex in the assay also
impaired the TRF1 ubiquitination (Figure 4B, compare lanes 4
with 6). Furthermore, addition of the Fbx4G domain (Figure 4C,
lanes 3–6) but not BSA (Figure 4C, lanes 7–10) inhibited the
TRF1 ubiquitination, suggesting that the observed ubiquitination
of TRF1 was not due to any copurified contaminant activities.
Collectively, these results indicated that the binding of Fbx4 to
TRF1 is essential for SCFFbx4-mediated ubiquitination of TRF1.
To facilitate quantitative detection of the ubiquitinated
substrate, we labeled TRF1 by phosphorylation using cyclin
B/Cdk1 in the presence of 33P-g-ATP before the in vitro ubiquiti-
nation assay. Although phosphorylation of TRF1 is dispensable
for its association with Fbx4 as indicated by the crystal structure
(Figures 1B, 3B, and 3C), it remains plausible that TRF1 phos-
phorylation by cyclin B/Cdk1 may facilitate TRF1 ubiquitination
due to an allosteric effect. To rule out this possibility, we carried
out the in vitro ubiquitination assay using TRF1 substrate in the
presence of cold ATP with or without phosphorylation by cyclin218 Developmental Cell 18, 214–225, February 16, 2010 ª2010 Elsevier Inc.B/Cdk1 and then detected the ubiquiti-
nated product by western blot. As shown
in Figure S4, both phosphorylated and
unphosphorylated TRF1 were efficiently
ubiquitinated by SCFFbx4. In fact, TRF1phosphorylation by cyclin B/Cdk1 slightly inhibited the
SCFFbx4-mediated TRF1 unbiquitination (Figure S4, compare
lanes 4 and 9). Therefore, we conclude that, unlike most other
cases where F-box proteins recognize the phosphorylated de-
gron peptide sequences of their substrates, phosphorylation is
unlikely to be a prerequisite for TRF1 ubiquitination by SCFFbx4.
Fbx4 Promotes TRF1 Degradation in Cells
To examine whether the observed Fbx4-TRF1 interaction is
important in Fbx4-dependent degradation of TRF1 in vivo, we
cotransfected TRF1 and UbcH5a together with Fbx4 or its
TRF1-binding-deficient mutant (Fbx4C341W/A345R) in human
embryonic kidney 293T cells and then monitored the steady-
state levels of TRF1. Overexpression of WT Fbx4 but not
Fbx4C341W/A345R greatly reduced the levels of TRF1 (Figure 4D,
compare lanes 2 and 4). Addition of proteasome inhibitor MG132
significantly elevated TRF1 levels in Fbx4-transfected cells, sug-
gesting that reduction of TRF1 reflects proteasome-mediated
degradation (Figure 4D, lane 1). We conclude that Fbx4-TRF1
association is essential for SCFFbx4-mediated TRF1 degradation.
Inhibition of the SCFFbx4-Mediated TRF1 Ubiquitination
by TIN2
Telomere localization of TRF1 is crucial for its stability. It has
been proposed that the DNA-binding Myb domain of TRF1 might
Figure 4. The Fbx4-TRF1 Interface Is Essential for Fbx4-Dependent TRF1 Ubiquitination
(A) Fbx4-dependent ubiquitination of TRF1. Purified recombinant TRF1 was 33P-labeled by protein kinase GST-cyclin B/Cdk1, and 33P-TRF1 was separated from
GST-cyclin B/Cdk1 by depletion with GSH beads. 33P-TRF1 was then incubated with purified recombinant E1, E2(UbcH5a), and E3(SCFFbx4) enzymes and
ubiquitin, methylated ubiquitin, ubiquitin aldehyde, and MG 132. Reaction mixtures were separated by SDS-PAGE, followed by PhosphorImaging analysis.
In (A)–(C), asterisks indicate the nonspecific ubiquitination products of TRF1 due to the presence of Cul1/Rbx1.
(B) The Fbx4-TRF1 interface is essential for Fbx4-dependent ubiquitination of TRF1. Reactions were performed as in (A), but TRF1L115R/L120R was used as
substrate in one reaction and SCFFbx4C341W/A345R as E3 ligase in another.
(C) Addition of Fbx4G suppresses Fbx4-dependent ubiquitination of TRF1. Ubiquitination assays were performed as in (A), but increasing amounts of Fbx4G
(3, 6, 12, 24 mM) or BSA (3, 6, 12, 24 mM) was added in the reactions.
(D) HEK293T cells were transfected with TRF1, UbcH5a, Fbx4 WT, or Fbx4 C341W/A345R. 4 hr after transfection, cells were split into two plates and grown for
24 hr prior to being treated with 2 mM MG 132 or DMSO for 16 hr. Cells were lysed and cell extracts were immunoblotted with indicated antibodies.
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Selective Ubiquitination of TRF1 by SCFFbx4contain the ubiquitin acceptor lysine and that the telomere
binding through this domain protects TRF1 from ubiquitination
(Chang et al., 2003). However, a TRF1 mutant lacking the Myb
domain, TRF1DMyb, can be efficiently modified in our ubiquiti-
nation assay, demonstrating the existence of lysines outside of
the Myb domain that can be ubiquitinated (Figure 5A). Further-
more, addition of either single-stranded or double-stranded
telomeric DNAs had no effect on TRF1 ubiquitination by SCFFbx4
(Figure 5B). Therefore, we conclude that telomere binding itself is
unlikely the mechanism of why telomere-bound TRF1 is pro-
tected from ubiquitination and degradation.
Given that TRF1 interacts with many proteins at telomeres, it is
likely that a TRF1-associated protein would inhibit TRF1 recog-
nition by SCFFbx4 and thus protect TRF1 from ubiquitination
and degradation. A possible candidate is TIN2, a component
of the telomeric shelterin complex (de Lange, 2005), which binds
to both TRF1 and TRF2 and is essential for their stability at telo-
meres (Kim et al., 1999, 2008,; Ye and de Lange, 2004). In a
previous study, we determined the crystal structure of TRF1TRFH
complexed with a short peptide of TIN2, TIN2TBM (TRF1 binding
motif) (Figure S5) (Chen et al., 2008). When the TRF1TRFH-
TIN2TBM and the Fbx4G-TRF1TRFH crystal structures are super-Developmimposed, it is clear that the TRF1TRFH-TIN2TBM interaction inter-
feres with Fbx4G binding to TRF1TRFH by introducing significant
spatial hindrance; the N terminus of the TIN2TBM peptide collides
with helix aD of Fbx4G (Figure 5C). Notably, the two phenol rings
from Phe342 of Fbx4G and Phe258 of TIN2TBM occupy exactly
the same binding site on TRF1TRFH (Figure 5C). Phe258 of TIN2
is a critical amino acid for the TRF1TRFH-TINTBM interaction; the
F258A mutation greatly reduced the TRF1 binding affinity of
TIN2TBM by more than 30-fold (Chen et al., 2008). Thus, this
observation suggested that TIN2 and Fbx4 cannot bind to
TRF1 simultaneously.
We next determined whether the TRF1-TIN2 interaction
sequesters TRF1 from recognition by Fbx4. In the GST pull-
down assay, when both Fbx4G and TIN2TBM were incubated
with GST-tagged TRF1TRFH, only TIN2TBM associated with
GST-TRF1TRFH, while both proteins could be pulled down
individually by GST-TRF1TRFH (Figure 5D). In contrast, a TRF1-
binding-deficient mutant of TIN2TBM (TIN2TBML260E) failed to
compete with Fbx4G for GST-TRF1TRFH binding (Figure 5D), indi-
cating that TIN2 has a higher binding affinity to TRF1 than Fbx4
does. Furthermore, when recombinant TIN2 was added in the
in vitro ubiquitination assay, ubiquitination of TRF1 was clearlyental Cell 18, 214–225, February 16, 2010 ª2010 Elsevier Inc. 219
Figure 5. TIN2 Blocks the Fbx4-TRF1 Interaction and Inhibits the Ubiquitination of TRF1 Mediated by SCFFbx4
(A) TRF1 deletion mutant lacking the DNA-binding Myb domain, TRF1DMyb, can be efficiently ubiquitinated by SCFFbx4.
(B) Addition of either WT or mutant telomere DNAs has no effect on TRF1 ubiquitination. In vitro ubiquitination reactions containing 33P-labeled TRF1 were carried
out in the absence () or presence of double-stranded (DS; 1, 12, or 36 mM TTAGGG or TTAGGC) repeat DNA or single-stranded (SS; 36 mM TTAGGG [G] or
AATCCC [C]) repeat DNA.
(C) Superposition of the Fbx4G-TRF1TRFH structure with the crystal structure of the TRF1TRFH-TIN2TBM complex. Fbx4G (cyan) and TIN2TBM (gray) share a common
hydrophobic interacting surface on TRF1TRFH (orange). An enlarged view of the collision between Fbx4G aD helix and the TIN2TBM peptide is highlighted in the box.
(D) GST pull-down competition assay of the Fbx4G-TRF1TRFH interaction in the presence of WT or the L260E mutant TIN2TBM peptides. For clarity, Sumo-fused
TIN2TBM peptides were used in this assay. Sumo itself does not bind to TRF1TRFH (data not shown).
(E) TIN2 inhibits Fbx4-mediated ubiquitination of TRF1. TRF1 ubiquitination assays were performed as in (A), but increasing amounts of TIN2 (3, 9, 27, 81 mM)
or mutant TIN2L260E (3, 9, 27, 81 mM) was added in the reactions. Asterisks indicate the nonspecific ubiquitination products of TRF1 due to the presence of
Cul1/Rbx1.
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Selective Ubiquitination of TRF1 by SCFFbx4inhibited (Figure 5E). This inhibition was not due to some nonspe-
cific effects of TIN2 since the TIN2 L260E mutant had no effect
on TRF1 ubiquitination (Figure 5E). Collectively, these structural220 Developmental Cell 18, 214–225, February 16, 2010 ª2010 Elsevand biochemical data showed that TIN2 can inhibit TRF1 recog-
nition by Fbx4 and prevent SCFFbx4-mediated TRF1 ubiquitina-
tion in vitro.ier Inc.
Figure 6. TRF1 Stabilization by TIN2 Depends on Fbx4
(A) HeLa cells expressing control or Fbx4 shRNA were transfected with
Flag-TRF1 along with either TIN2 or an empty expression vector. The expres-
sion levels of Flag-TRF1, TIN2, and Fbx4 were analyzed by immunoblotting
with the respective antibodies. b-tubulin was blotted as the loading control.
(B) Immunoblotting analysis of the endogenous levels of TRF1 in HeLa cells
stably expressing control, TRF1, Fbx4, or TIN2 shRNA vectors with the
indicated antibodies.
(C) Endogenous levels of TRF1 in Fbx4 or TIN2 single or double knockdown
cells as determined by immunoblotting with the indicated antibodies.
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DevelopmTIN2 Suppresses Fbx4-Dependent TRF1 Degradation
in Cells
If TIN2 inhibits Fbx4-mediated ubiquitination and degradation of
TRF1 in cells, overexpression of TIN2 should protect TRF1 from
degradation and cause it to accumulate. The protection effect
should be more pronounced in WT cells than Fbx4 knockdown
cells. To test this hypothesis, we first knocked down the endog-
enous Fbx4 in HeLa cells using a lentiviral short hairpin RNA
(shRNA) that targets Fbx4. In agreement with the previous obser-
vations, stable expression of Fbx4 shRNA but not the control
shRNA causes a reduction in Fbx4 expression (Figure 6A)
(Chang et al., 2003; Lee et al., 2006). Subsequently, Flag-tagged
TRF1 and TIN2 (or empty vector) were transiently transfected
into Fbx4 and control shRNA-treated cells, and the amount of
Flag-TRF1 was assayed by immunoblotting. Notably, whereas
no significant change in the amount of Flag-TRF1 was observed
in Fbx4 knockdown cells with or without TIN2 (Figure 6A,
compare lanes 1 and 2), there is a significant increase in Flag-
TRF1 levels when TIN2 was cotransfected in control shRNA cells
(Figure 6A, compare lanes 3 and 4). Since the expression levels
of TIN2 were comparable in control or Fbx4 shRNA-treated cells
(Figure 6A, compare lanes 1 and 3), these results suggested that
TIN2-induced stabilization of TRF1 requires Fbx4 and TIN2 does
not afford additional stabilization of TRF1 without Fbx4.
To examine the roles of Fbx4 and TIN2 in regulating the endog-
enous levels of TRF1, we determined the effect of depletion of
Fbx4 and TIN2 on accumulation of TRF1 in cells. Consistent
with previous studies, knockdown of Fbx4 and TIN2 reproduc-
ibly resulted in increased and decreased levels of TRF1, respec-
tively (Figure 6B) (Lee et al., 2006; Ye and de Lange, 2004),
suggesting that Fbx4 promotes endogenous TRF1 degradation
whereas TIN2 stabilizes the TRF1 protein level. To establish
the direct connection between TIN2 and Fbx4 in TRF1 regula-
tion, we next asked whether the reduction of the TRF1 protein
level in TIN2 shRNA cells depends upon Fbx4. As shown in
Figure 6C, reduction of TRF1 caused by TIN2 depletion can be
abrogated by depletion of Fbx4 (compare lanes 2 and 3). The
level of TRF1 in TIN2 and Fbx4 double knockdown cells is
virtually identical to that in Fbx4 knockdown cells (Figure 6C,
compare lanes 3 and 4), indicating that the TIN2-induced stabi-
lization of endogenous TRF1 depends on Fbx4. Taken together,
our in vitro and in vivo studies provide a mechanism by which
interaction between TIN2 and TRF1 inhibits the ubiquitination
of TRF1 by SCFFbx4 and thus prevents TRF1 from degradation.
DISCUSSION
An Unusual Substrate Recognition Domain in Fbx4
SCF ubiquitin ligases regulate a myriad of cellular and develop-
ment processes, and the molecular basis of how they selectively
recruit substrates is a key issue in ubiquitin biology. The
substrate receptor F-box proteins invariably contain an F-box
domain at the N-terminal region and a substrate-recognition
domain at the C-terminal region. Unlike the well-characterized
Fbw and Fbl families of F-box proteins, the molecular mecha-
nisms of how Fbx family proteins recognize their substrates are
largely unknown. One of the few known examples is the Fbs
subfamily, which uses a b sandwich-containing sugar-binding
domain (SBD) to recognize N-glycan (Yoshida et al., 2002). Inental Cell 18, 214–225, February 16, 2010 ª2010 Elsevier Inc. 221
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receptor Fbx4 contains an unexpected atypical small GTPase
domain. Functional analysis confirmed that key residues within
this domain directly mediate binding to TRF1. Atypical small
GTPases represent a class of signaling molecules different
from the classical small GTPases by virtue of their deficiency in
nucleotide binding and the distinct biological processes they
regulate (Aspenstrom et al., 2007). The Fbx4-TRF1 complex
structure and subsequent biochemical analysis validated the
hypothesis that the atypical small GTPase domain functions as
a protein-protein interaction module rather than a GTP hydro-
lyzing enzymatic domain (Aspenstrom et al., 2007; Chang
et al., 2006). Since the atypical small GTPase cannot be readily
predicted from the primary sequence, it will be important to
determine whether other Fbx proteins may also harbor this func-
tional domain. Utilization of an atypical small GTPase fold for
substrate recruitment may not be limited to SCF. RhoBTBs (1,
2, and 3), which contain both an atypical small GTPase domain
and at least one Broad Complex/Tramtrack/Bric-a-brac (BTB)
domain, have recently been shown to be the adapters and
substrate receptors of CUL3 ubiquitin ligases (Wilkins et al.,
2004). The substrates for RhoBTB1–3 have not yet been identi-
fied. Based on our studies, it is tempting to speculate that the
atypical GTPase domains may be the substrate interaction motif
for CUL3 ligases.
Specificity of Substrate Recognition by Fbx4
Unlike many well-characterized SCF substrates, which invari-
ably undergo posttranslational modifications (e.g., phosphoryla-
tion, sugar modification, hydroxylation of proline) or denaturation
for recognition by the respective F-box adaptors (Petroski and
Deshaies, 2005; Ravid and Hochstrasser, 2008), SCFFbx4 recog-
nizes an unmodified structural motif of TRF1 (Figure 1B). The
remarkable specificity of Fbx4-substrate interaction is further
underscored by stringent substrate discrimination between
TRF1 and TRF2. Hence, structural insights into the Fbx4-TRF1
complex revealed that there is much greater specificity for a
subset of SCF-substrate binding than was previously thought.
There are many examples of E3-short peptide substrate
complex structures (Hao et al., 2005, 2007; Min et al., 2002;
Wu et al., 2003; Zhuang et al., 2009). While short peptides do
exhibit specific binding to the F-box proteins, it is possible that
these short peptides do not represent all of the binding interfaces
of the full-length substrates. The Fbx4-TRF1 structure, which
contains an extended substrate, raises a possibility that F-box
protein may recognize a highly structured substrate in addition
to the short degron peptide signal.
In addition to TRF1, recent work has also identified cyclin
D1 as another substrate for Fbx4-dependent ubiquitination
(Lin et al., 2006). Ubiquitination of cyclin D1 requires phosphory-
lation at Thr286 and the presence of an adaptor protein aB-crys-
tallin (Lin et al., 2006). In contrast, our data showed that TRF1
ubiquitination by SCFFbx4 is aB-crystallin independent and
that phosphorylation of TRF1 is dispensable for its association
with Fbx4. Thus, Fbx4 is capable of mediating both phosphory-
lated and unphosphorylated substrate ubiquitination and
degradation in the context of two different SCF ligases, SCFFbx4
and SCFFbx4-aB Crystallin, respectively. Definitive clarification of
different modes of substrate recognition by Fbx4 has to wait until222 Developmental Cell 18, 214–225, February 16, 2010 ª2010 Elsevthe crystal structure of the Fbx4-cyclin D1-aB-crystallin complex
becomes available.
While phosphorylation of TRF1 by Cyclin B/Cdk1 is dispens-
able for TRF1 ubiquitination in vitro, we cannot rule out the possi-
bility that TRF1 phosphorylation by cyclin B/Cdk1 may promote
its ubiquitination by SCFFbx4 in vivo. Cdk1 activity is required for
telomere addition in yeast (Frank et al., 2006), and Cdc13
appears to be a target of Cdk1 (Li et al., 2009). In this vein, phos-
phorylation of TRF1 by cyclin B/Cdk1 could affect its ubiquitina-
tion by SCFFbx4. Further studies are required to address the
physiological significance of TRF1 phosphorylation by cyclin B/
Cdk1.
Posttranslational Modifications of TRF1
and Their Roles in TRF1 Dynamic Regulation
TRF1 stability and its dynamic localization to telomeres are regu-
lated by multiple posttranslational modifications. In human cells,
TRF1 is poly(ADP-ribosyl)ated by tankyrase 1, and this leads to
TRF1 eviction from telomeres and subsequently to ubiquitination
and degradation by the ubiquitin/proteasome pathway (Smith
et al., 1998). Previous studies by others indicated that TIN2
stabilizes TRF1 on telomeres by protecting TRF1 from poly
(ADP-ribosyl)ation by tankyrase 1 (Ye and de Lange, 2004).
Here, our structural and biochemical studies reveal another link
between TIN2 and posttranslational modification of TRF1. TIN2
suppresses TRF1 polyubiquitination by sequestering its degra-
dation motif from recognition by Fbx4 when both are assembled
to form the shelterin complex to cap the chromosome ends.
Thus, TIN2 serves as a double safe to prevent TRF1 release
from telomeres in human cells. Our data also suggest that the
telomere-unbound form of TRF1 is relatively unstable and sub-
jected to Fbx4-mediated ubiquitination and degradation (Chang
et al., 2003; Lee et al., 2006). However, we do not yet know
whether TIN2 disassociates with TRF1 after TRF1 release from
telomeres. A recent in vivo quantitative analysis of shelterin
proteins demonstrated that most TRF1 molecules are associ-
ated with telomeres with no detectable telomere-unbound
TRF1 in cells (Takai et al., 2010), indicating that telomere-
unbound TRF1 is unstable and subjected to degradation. Taken
together, it is very likely that TRF1 is no longer associated with
TIN2 after being evicted from telomeres. Further work is needed
to test this hypothesis.
Degradation by the proteasome is not the only fate of polyubi-
quitinated TRF1. A recent study showed that polyubiquitinated
TRF1 can also be deubiquitinated and stabilized by ubiquitin-
specific protease 22 (Usp22) in a Gcn5-containing SAGA
complex (Atanassov et al., 2009). Notably, our studies reveal
that depletion of TIN2 only yielded modest reduction in the
TRF1 level (Figure 6B). This is consistent with the new finding
that a portion of ubiquitinated TRF1 is deubiquitinated, stabi-
lized, and possibly recycled back to telomeres.
The dynamic regulation of TRF1 on and off telomeres by post-
translational modifications and their controllers (for example,
TIN2 and tankyrase 1) appears to play an important role in telo-
mere homeostasis maintenance (Smith, 2009). TRF1 serves as a
negative regulator of telomere length maintenance (van Steensel
and de Lange, 1997). Therefore, release of TRF1 from telomeres
may be necessary to allow telomerase to access the chromo-
some ends for telomere extension. Furthermore, it has beenier Inc.
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conformation and are recognized as damaged DNAs in the G2
phase of the cell cycle (Deng et al., 2009; Verdun et al., 2005;
Verdun and Karlseder, 2006). It is likely that after replication,
TRF1 also needs to be reorganized on telomeres in order to
have telomeres properly processed to form a functional protec-
tive structure. On the other hand, protecting TRF1 from ubiquiti-
nation by TIN2 on telomeres and recycling TRF1 back to
telomeres through deubiquitination may be important in S phase,
during which TRF1 is required for efficient telomere DNA replica-
tion (Sfeir et al., 2009). In addition, TIN2 is the central component
of shelterin and interacts with TRF1, TRF2, and TPP1 simulta-
neously, providing a potential mechanism through which the
regulation of TRF1 posttranslational modification is linked to
other shelterin proteins. Working out how and when all these
complicated and interdigitated mechanisms cooperate to
control TRF1 dynamics and telomere homeostasis remains a
major challenge for the future. Nevertheless, given the specificity
of the TRF1-Fbx4 binding interface, it is possible to develop
selective small molecule inhibitors that specifically perturb inter-
action between Fbx4 and TRF1. Such inhibitors may be novel
antitumor therapeutic agents, as they are expected to cause
shortening of telomeres and apoptosis of cancer cells.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Human TRF1TRFH (residues 58–268) was cloned into a GST fusion protein
expression vector, pGEX6p-1 (GE healthcare) and Fbx4G (residues 162–387)
into a modified pET28b vector with a Sumo protein fused at the N terminus
after the His6 tag (Wang et al., 2007). The Fbx4G-TRF1TRFH complex was coex-
pressed in E. coli BL21(DE3). After induction for 16 hr with 0.1 mM IPTG at
25C, the cells were harvested by centrifugation and the pellets were resus-
pended in lysis buffer (50 mM Tris-HCl [pH 8.0], 50 mM NaH2PO4, 400 mM
NaCl, 3 mM imidazole, 10% glycerol, 1 mM PMSF, 0.1 mg/ml lysozyme,
2 mM 2-mercaptoethanol, and homemade protease inhibitor cocktail). The
cells were then lysed by sonication, and the cell debris was removed by ultra-
centrifugation. The supernatant was mixed with Ni-NTA agarose beads
(QIAGEN) and rocked for 6 hr at 4C before elution with 250 mM imidazole.
Then Ulp1 protease was added to remove the His6-Sumo tag. The complex
was then mixed with glutathione sepharose beads (GE Healthcare) and rocked
for 8 hr at 4C before elution with 15 mM glutathione. Protease 3C was added
to remove the GST tag. Finally, the Fbx4G-TRF1TRFH complex was further puri-
fied by passage through Mono-Q ion-exchange column and by gel-filtration
chromatography on Hiload Superdex200 equilibrated with 25 mM Tris-HCl
(pH 8.0), 150 mM NaCl, and 5 mM dithiothreitol (DTT). The purified Fbx4G-
TRF1TRFH complex was concentrated to 7 mg/ml and stored at 80C.
For the GST-pull-down assay, WT and mutant GST-TRF1TRFH, GST-
TRF2TRFH, His6-Sumo-Fbx4G, and His6-Sumo-TIN2TBM were expressed in
E. coli and purified following the same procedure as described above except
that only one affinity chromatography step was used according to the tags of
the proteins. The His6-Sumo tag of Fbx4G was cleaved by Ulp1 protease.
For the in vitro ubiquitination assay, TRF1 deletion mutant TRF1DMyb and
full-length WT and mutant TIN2 and TRF1 proteins were expressed in E. coli
as N-terminal His6-Sumo tag fusions, and they were purified by Ni-NTA affinity
chromatography followed by Ulp1 digestion to cleave the His6-Sumo tag and
finally by gel filtration chromatography. GST-tagged Fbx4 with two deletions
(residues 1–54 and 150–170) was coexpressed with truncated Skp1 (Schul-
man et al., 2000) as a dicistronic message in E. coli, and the complex was
purified by glutathione-affinity chromatography followed by thrombin cleavage
of the GST tag and by gel filtration chromatography. Deletions of Fbx4 and
Skp1 were made to increase the solubility and stability of the complex. The
human E1, UbcH5a (E2), Cul1-Rbx1, and Skp1-Skp2 were produced as
described (Chen et al., 2008; Hao et al., 2005).DevelopmCrystallization, Data Collection, and Structure Determination
of Fbx4G-TRF1TRFH
The Se-Met-substituted Fbx4G-TRF1TRFH complex crystals were grown by
hanging drop vapor diffusion at 16C. The precipitant/well solution contained
300 mM NH4H2PO4, 100 mM sodium citrate (pH 6.2), 10% n-propanol, and
10 mM DTT. Crystals were gradually transferred into a harvesting solution con-
taining 200 mM NH4H2PO4, 100 mM sodium citrate (pH 6.2), 10 mM DTT, and
5 M sodium formate. To improve the diffraction resolution, the crystals were
briefly soaked in the harvesting solution in the presence of 100 mM NaBr for
10 min before being flash-frozen in liquid nitrogen for storage, and data
were collected under cryogenic conditions (100 K). Se-Met-MAD data sets
at the Se peak and inflection wavelengths were collected using one crystal
at beamline 21ID-D at APS. Crystals belong to space group P43212 and with
unit cell parameters refined to a = b = 68.097 A˚ and c = 234.421 A˚ for the
peak wavelength data set. The two data sets were processed using
HKL2000 (Otwinowski and Minor, 1997). Twelve selenium atoms were located
and refined, and the MAD phases were calculated using SHARP (De La Fortelle
and Bricogne, 1997). The initial MAD map was significantly improved by
solvent flattening. A model was automatically built into the modified experi-
mental electron density using ARP/WARP (Lamzin et al., 2001); the model
was then further refined using simulated-annealing and positional refinement
in CNS (Brunger et al., 1998) with manual rebuilding (O) (Jones et al., 1991).
Fluorescence Polarization Assay
We monitored the polarization of light emitted after the addition of 1 mM BOD-
IPY FL GTPgS (excitation/emission maxima 503/512 nm; Invitrogen) to a
reaction mixture containing 2 mM protein sample (Fbx4G, Fbx4G-TRF1TRFH,
RhoA, or p63RhoGEF) in 20 mM HEPES (pH 8.0), 150 mM NaCl, 10% glycerol,
10 mM MgCl2, and 1 mM DTT. Samples were excited with plane-polarized light
using a BMG LABTECH PHERAstar with 485/520 FP Module. Millipolarization
(mP) of the emitted light was plotted versus time. The signal from the fluoro-
phore alone is first subtracted from each curve.
Yeast Two-Hybrid Assay
The yeast two-hybrid assays were performed using L40 strain harboring
pBTM116 and PACT2 (Clontech) fusion plasmids. The colonies containing
both plasmids were selected on –Leu –Trp plates. b-galactosidase activities
were measured by liquid assay (Moretti et al., 1994).
In Vitro GST Pull-Down Assay
5 mg of purified GST or GST-fusion proteins (GST-TRF2TRFH, GST-TRF1TRFH,
or its mutants [GST-TRF1TRFHL115R and GST-TRF1TRFHL120R]) was incu-
bated with 10 mg wild-type or mutant (C341W) Fbx4G at 4
C for 16 hr in
40 ml binding buffer (25 mM Tris-HCl [pH 8.0], 150 mM NaCl, and 5 mM DTT)
containing 5 ml glutathione sepharose beads. For the competition assay,
5 mg of GST-TRF1TRFH was incubated with 10 mg Fbx4G in the presence of
10 mg of His6-Sumo-TIN2TBM or its L260E mutant proteins. The glutathione
sepharose beads were then washed three times by 100 ml binding buffer
and finally resuspended in 20 ml 2 3 SDS protein sample buffer. The samples
were analyzed by SDS-PAGE.
In Vitro Ubiquitination Assay
Wild-type or mutant TRF1 proteins were labeled with [g-33P]ATP by in vitro
kinase assay. TRF1 proteins (4 mM) were phosphorylated by incubating with
the GST-cyclin B/Cdk1 complex (0.1 mM) in 13 kinase reaction buffer contain-
ing 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 10 mM ATP, and 2 mCi of [g-
33P]ATP
for 1 hr. The phosphorylated TRF1 was separated from GST-cyclin B/Cdk1 by
glutathione affinity chromatography. The ubiquitination assays were performed
by incubating phosphorylated TRF1 with 0.5 mM E1, 5 mM UbcH5a (E2), 1 mM
SCFFbx4 E3 complex, 5 mM ubiquitin (Sigma), 100 mM methylated ubiquitin
(BostonBiochem), 1 mM ubiquitin aldehyde (BostonBiochem), 50 mM MG 132
(Calbiochem), and 1 ml 20 3 energy regeneration system (10 mM ATP, 20 mM
HEPES [pH 7.4], 10 mM MgOAc, 300 mM creatine phosphate, and 0.5 mg/ml
creatine phosphokinase) in a final volume of 20ml. The reactions were incubated
at 30C for 2 hr, terminated by boiling in SDS protein sample buffer, and
analyzed by SDS-PAGE. Gels were dried prior to phosphoimaging analysis.
For ubiquitination of TRF1 without phosphorylation, we incubated recombi-
nant Flag-TRF1 protein purified from E. coli with the recombinant SCFFbx4ental Cell 18, 214–225, February 16, 2010 ª2010 Elsevier Inc. 223
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to detect TRF1 ubiquitin conjugates.
To investigate whether telomeric DNAs inhibit TRF1 ubiquitination by
SCFFbx4, oligonucleotides containing GATCTAGCT(TTAGGG)6 and (CCCTAA)6
AGCTAGATC for DS (TTAGGG) or GATCTAGCT(TTAGGC)6 and (GCCTAA)6
AGCTAGATC for DS (TTAGGC) and GATCTAGCT(TTAGGG)6 for SS(G) or
GATCTAGCT(TTAGGC)6 for SS(C) were used. Oligonucleotides were pur-
chased from Invitrogen. 33P-labeled TRF1 was incubated with DS or SS oligo-
nucleotides at 30C for 30 min prior to addition to the ubiquitination reactions.
Cell Culture, Transfection, and Immunoblotting Analysis
293T cells were purchased from ATCC and maintained at 37C in a 5% CO2
atmosphere in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum (FCS; Invitrogen), penicillin (100 IU/ml), streptomycin
(100 mg/ml), and L-glutamine (2 mM, Invitrogen). The cDNAs encoding TRF1,
Fbx4, Fbx4 C341W/A345R, UbcH5a, or TIN2 were subcloned into mammalian
expression vector pEXL and used for the transfection of 293T cells by PEI. 4 hr
after transfection, one plate of cells was split into two plates. 24 hr after trans-
fection, cells were treated with 2 mM MG-132 or DMSO for 16 hr and harvested.
Cell lysates were prepared in the lysis buffer (50 mM Tris-HCl [pH 7.4],
200 mM NaCl, 1 mM EDTA, 1% NP40, and 15% glycerol). The protein concen-
trations were measured by Bradford assay (Biorad). Samples were resolved on
12% SDS-PAGE and electrophoretically transferred to nitrocellulose. Western
blots were performed using the anti-Flag M2 (Stratagene), anti-TRF1 (Ye and
de Lange, 2004), anti-Fbx4 (Lin et al., 2006), anti-TIN2 (Kim et al., 1999), and
anti-Tubulin (ICN) antibodies. The proteins were detected using HRP conju-
gated goat-anti-mouse or rabbit secondary antibody (GE Healthcare) with
an ECL WesternDura detection kit (Pierce).
Generation of Stable shRNA Knockdown Cell Lines
Stable cell lines expressing shRNA constructs targeting Fbx4, TIN2, or TRF1
were created by lentiviral-mediated gene transfer. In brief, shRNA lentiviral
constructs targeting Fbx4 (CCGATTGATGTACAGCTATAT), TIN2 (CGACGAG
GAGCAGTTCGAA), and TRF1 (CGACGAGGAGCAGTTCGAA) were made in
a modified lentiviral vector FG12-Puro (Qin et al., 2003). Lentiviruses were
produced by transient transfection packing using 293T cells as described
previously (Riquelme et al., 2006). Fresh viruses were used to infect HeLa S3
cells, and stable cell lines were established by selecting with 2 mg/ml of puro-
mycin for 2 weeks.
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